TB Alliance fails to get patent for six-month treatment regimen

The Indian Patent Office on Tuesday rejected a patent application for BPaL, a combination of three medicines that has cut treatment for drug-resistant tuberculosis (TB) to six months, according to a joint statement by the groups that opposed it

Khabar Adda curates headlines like this across Top Stories, Entertainment, Bollywood, Hollywood, Crime and Politics from public RSS feeds. This page links out to Hindustan Times's own reporting rather than reproducing it — the excerpt above comes from Hindustan Times's own feed.